Product Information
ACETAMINOPHEN-COD #4 TABLET is a generic product labeled by Eywa Pharma Inc, priced at $0.3864 per EA under NDC 71930005612. Its NADAC has been published 351 times since Oct 9, 2019.
Strength
300; 60 mg/1; mg/1
Manufacturer
Eywa Pharma IncNDC
71930005612
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA211610On Market Since
8/2/2019
Pharmacological Classes
Price Statistics
The NADAC for ACETAMINOPHEN-COD #4 TABLET has been published 351 times since Oct 9, 2019, and over the history we have for it it has risen 74.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3864 per EA |
|---|---|
| All-time high | $0.4850 (Jul 10, 2024) |
| All-time low | $0.1905 (Jul 21, 2021) |
| 52-week high | $0.4473 |
| 52-week low | $0.3855 |
| Median price | $0.3348 |
| Average price | $0.3134 |
| Largest weekly change | +39.0% (Dec 21, 2022) |
| Weeks tracked | 351 |
| Tracking since | Oct 9, 2019 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN-COD #4 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN-COD #4 TABLET, manufactured by Eywa Pharma Inc, is $0.3864 per EA (NDC 71930005612), effective Jun 24, 2026.
How has the price of ACETAMINOPHEN-COD #4 TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN-COD #4 TABLET has risen 74.1%. It has been tracked across 351 weekly CMS publications since Oct 9, 2019.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN-COD #4 TABLET?
Since Oct 9, 2019, the NADAC for ACETAMINOPHEN-COD #4 TABLET has ranged from a low of $0.1905 (Jul 21, 2021) to a high of $0.4850 (Jul 10, 2024), with a median of $0.3348 per EA.
Are there cheaper alternatives to ACETAMINOPHEN-COD #4 TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ACETAMINOPHEN-COD #4 TABLET, but none are currently priced below it.
Who manufactures ACETAMINOPHEN-COD #4 TABLET?
ACETAMINOPHEN-COD #4 TABLET (NDC 71930005612) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.
Related Drugs
Same classification